BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12810724)

  • 21. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.
    Shin J; Park B; Cho S; Lee S; Kim Y; Lee SO; Cho K; Lee S; Jin BS; Ahn JH; Choi EJ; Ahn K
    J Biol Chem; 2004 Sep; 279(39):40994-1003. PubMed ID: 15273249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chk2 leaves the PML depot.
    Venere M; Mochan TA; Halazonetis TD
    Nat Cell Biol; 2002 Nov; 4(11):E255-6. PubMed ID: 12415282
    [No Abstract]   [Full Text] [Related]  

  • 23. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.
    Stad R; Little NA; Xirodimas DP; Frenk R; van der Eb AJ; Lane DP; Saville MK; Jochemsen AG
    EMBO Rep; 2001 Nov; 2(11):1029-34. PubMed ID: 11606419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.
    Goldberg Z; Vogt Sionov R; Berger M; Zwang Y; Perets R; Van Etten RA; Oren M; Taya Y; Haupt Y
    EMBO J; 2002 Jul; 21(14):3715-27. PubMed ID: 12110584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced degradation of MDM2 by a nuclear envelope component, mouse germ cell-less.
    Masuhara M; Nagao K; Nishikawa M; Kimura T; Nakano T
    Biochem Biophys Res Commun; 2003 Sep; 308(4):927-32. PubMed ID: 12927808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
    Jin Y; Zeng SX; Lee H; Lu H
    J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to activate p53.
    Caspari T
    Curr Biol; 2000 Apr; 10(8):R315-7. PubMed ID: 10801407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction.
    Yang Q; Liao L; Deng X; Chen R; Gray NS; Yates JR; Lee JD
    Oncogene; 2013 Jun; 32(26):3156-64. PubMed ID: 22869143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDM2 negatively affects the Chk2-mediated phosphorylation of p53.
    Bjørling-Poulsen M; Meek D; Issinger OG
    FEBS Lett; 2005 May; 579(12):2604-8. PubMed ID: 15862297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.
    Fanelli M; Fantozzi A; De Luca P; Caprodossi S; Matsuzawa S; Lazar MA; Pelicci PG; Minucci S
    J Biol Chem; 2004 Feb; 279(7):5374-9. PubMed ID: 14645235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
    Joe Y; Jeong JH; Yang S; Kang H; Motoyama N; Pandolfi PP; Chung JH; Kim MK
    J Biol Chem; 2006 Sep; 281(39):28764-71. PubMed ID: 16891316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage-induced MDMX degradation is mediated by MDM2.
    Kawai H; Wiederschain D; Kitao H; Stuart J; Tsai KK; Yuan ZM
    J Biol Chem; 2003 Nov; 278(46):45946-53. PubMed ID: 12963717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
    Di Stefano V; Blandino G; Sacchi A; Soddu S; D'Orazi G
    Oncogene; 2004 Jul; 23(30):5185-92. PubMed ID: 15122315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons.
    Zhu Y; Mao XO; Sun Y; Xia Z; Greenberg DA
    J Biol Chem; 2002 Jun; 277(25):22909-14. PubMed ID: 11948180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
    Gu J; Nie L; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.